Maruff, P. (Dec 1, 2025). Meaningfulness to patents with preclinical AD of thinking measured by digital cognitive tests in Trial Blazer‐Alz III clinical trial. Alzheimer's & Dementia. https://doi.org/10.1002/alz70857_103915
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Maruff, Paul. "Meaningfulness to Patents with Preclinical AD of Thinking Measured by Digital Cognitive Tests in Trial Blazer‐Alz III Clinical Trial."
Alzheimer's & Dementia Dec 1, 2025. https://doi.org/10.1002/alz70857_103915.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Maruff, Paul. "Meaningfulness to Patents with Preclinical AD of Thinking Measured by Digital Cognitive Tests in Trial Blazer‐Alz III Clinical Trial."
Alzheimer's & Dementia, Dec 1, 2025, https://doi.org/10.1002/alz70857_103915.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.